Source: news.google.com
Cancer, specifically breast cancer, is the subject of Pfizer’s second season of its “Science Will Win” podcast debuting this week. Researchers, clinicians, and patients themselves will discuss the science, new innovations in targeted immunotherapies, clinical trials, and the physiological and personal challenges of the disease.
The two-episode season opens Thursday hosted by University College London geneticist and professor Adam Rutherford, who also hosted the first season of “Science Will Win” about gene therapy and the next generation of drugs.
Read more Endpoints with a free subscription
Unlock this story instantly and join the 152,000+ biopharmaceutical professionals who read Endpoints every day, and it’s free.
Read More at news.google.com